Extensive metastatic Kaposi sarcoma in chronic immune suppressed bronchial asthma
Krüssmann, A.; Goerg, R.; Laberke, H.G.; Weidner, F.O.
Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 44(4): 232-234
1993
ISSN/ISBN: 0017-8470 PMID: 8482604 Document Number: 418863
In a severely ill 64-year-old man with multilocular Kaposi sarcoma HIV infection was excluded. The decisive factor in the pathogenesis, was long-term immunosuppression with systemic corticosteroids for bronchial asthma. The patient died from cardiorespiratory insufficiency in the course of tumour progression. Autopsy revealed a vast visceral manifestation of Kaposi sarcoma.
Document emailed within 1 workday
Related Documents
Warmuth, I.; Moore, P.S. 1997: Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality? Archives of Dermatology 133(1): 83-85Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925
Simonart, T.; Dobbeleer, G.D.; Peny, M.; Fayt, I.; Parent, D.; Vooren, J.; Noel, J. 1999: Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions European Journal of Dermatology: Ejd 9(6): 480-482
Lustbader, I.; Sherman, A. 1987: Primary gastrointestinal Kaposi's sarcoma in a patient with acquired immune deficiency syndrome American Journal of Gastroenterology 82(9): 894-895
Wamburu, G.; Masenga, E.J.; Moshi, E.Z.; Schmid-Grendelmeier, P.; Kempf, W.; Orfanos, C.E. 2006: HIV - associated and non - HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence European Journal of Dermatology: Ejd 16(6): 677-682
Huang, K.-M.; Hsu, C.-H.; Cheng, J.C.-H.; Lai, M.-K.; Jeng, S.-C.; Ting, L.-L.; Huang, W.-T. 2006: Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent Anticancer Research 26(6c): 4659-4663
Reinfuss, M. 1987: Kaposi's sarcoma. Clinical picture, treatment and prognosis. I. Clinical forms of Kaposi's sarcoma Nowotwory 37(3): 195-206
Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526
Hille, J.J.; Phillips, J.I.; Petit, J.C.; Simpson, R.H. 1985: Oral Kaposi's sarcoma in a patient with the acquired immune deficiency syndrome. A case report with notes on management and safety Journal of the Dental Association of South Africa 40(6): 321-325
Von Overbeck, J.; Perey, L.; Iten, A.; Pechère, M.; Ruffieux, P.; Hirschel, B. 1995: Human chronic gonadotropin for AIDS-related Kaposi's sarcoma Lancet 346(8975): 642-643
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
Ballke, E.H.; Wiersbitzky, S.; König, A.; Jährig, K. 1992: Transepithelial potential difference in the bronchial system of children with chronic bronchitis and bronchial asthma Padiatrie und Grenzgebiete 31(2): 103-105
Kogosova, L.S.; Kovalenko, N.N.; Strafun, O.V.; Markov, A.E. 1990: The effect of vilozen on the immune status of bronchial asthma patients Vrachebnoe Delo 10: 48-50
Poniakina, I.D.; Lebedev, K.A.; Arshinova, S.A.; Chervinskaia, T.A.; Bashum, E.P. 1987: Characteristics of the immune system balance of patients with infectious-allergic bronchial asthma Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 46-50
Vernik, A.G.; Bogomaz, T.A.; Khavinson, V.K. 1987: Immune status of children with bronchial asthma and an assessment of the effectiveness of treatment with thymalin Pediatriia 9: 106-107
Szczepanowska, A.; Modzelewska, I.; Piórkowska, E.; Kołłataj, W.; Gajewska-Obel, E.; Kornas-Dubejko, A.; Gurdziel, Z. 1992: Effect of treatment with HDM vaccine on selected immune parameters in children with bronchial asthma Wiadomosci Lekarskie 45(21-22): 808-811
Dziedziczko, A.; Tujakowski, J. 1981: Practical value of the study of bronchial reactivity in the diagnosis of bronchial asthma and asthma susceptibility in conscripts Polski Tygodnik Lekarski 36(34): 1301-1304
Bogoliubov, V.M.; Maliavin, A.G.; Pershin, S.B.; Shubina, A.V.; Kubli, S.K. 1985: Status of the immune system of patients with infectious-allergic bronchial asthma after transcerebral exposure to a UHF electrical field (27, 12 MHz) Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 10-13
Blankstein, A.; Spitzer, S. 1973: Salbutamol in chronic bronchial asthma Harefuah 84(12): 655-658
Webb, D.R.; Mullarkey, M.F.; Freeman, M.I. 1979: Flunisolide in chronic bronchial asthma Annals of Allergy 42(2): 80-82